¿Qué es la enfermedad de Alzheimer?






descargar 0.56 Mb.
título¿Qué es la enfermedad de Alzheimer?
página4/9
fecha de publicación27.03.2017
tamaño0.56 Mb.
tipoDocumentos
med.se-todo.com > Documentos > Documentos
1   2   3   4   5   6   7   8   9

4.- Residencias y otros servicios.

A menudo se llega a un momento en que incluso el cuidador más abnegado debe recurrir a la institucionalización de su familiar enfermo. No sólo determina este momento el "aguante" emocional del cuidador, sino también sus facultades y vigor físico y su mismo estado de salud. Con frecuencia son criterios económicos los que llevan a la elección de un determinado centro, pero también habría que tener en cuenta el tipo de cuidados que se pueden obtener. Aunque hasta más de la mitad de la mitad de los pacientes de residencias son enfermos de Alzheimer, no es normal que existan programas específicos para ellos. O a veces se encuentra el sitio que ofrece una atención especializada, pero se encuentra alejado del domicilio familiar. En estos casos, habrá que considerar cuidadosamente si compensa ese tipo de atención con una mayor dificultad para las visitas y contacto más cotidiano con el familiar enfermo, lo cual también es con frecuencia motivo de sufrimiento para los familiares.

Para saber más...





1: Demissie S, Green RC, Mucci L, Tziavas S, Martelli K, Bang K, Coons L,Bourque S, Buchillon D, Johnson K, Smith T, Sharrow N, Lautenschlager N,
Friedland R, Cupples LA, Farrer LA.
Reliability of information collected by proxy in family studies of Alzheimer's
disease.
Neuroepidemiology. 2001 May;20(2):105-11.
PMID: 11359077 [PubMed - indexed for MEDLINE]


2: Heun R, Papassotiropoulos A, Jessen F, Maier W, Breitner JC.A family study of Alzheimer disease and early- and late-onset depression in
elderly patients.
Arch Gen Psychiatry. 2001 Feb;58(2):190-6.
PMID: 11177121 [PubMed - indexed for MEDLINE]


3: Bertram L, Blacker D, Crystal A, Mullin K, Keeney D, Jones J, Basu S, Yhu S,Guenette S, McInnis M, Go R, Tanzi R.
Candidate genes showing no evidence for association or linkage with Alzheimer's
disease using family-based methodologies.
Exp Gerontol. 2000 Dec;35(9-10):1353-61.
PMID: 11113613 [PubMed - indexed for MEDLINE]


4: Devi G, Fotiou A, Jyrinji D, Tycko B, DeArmand S, Rogaeva E, Song YQ,Medieros H, Liang Y, Orlacchio A, Williamson J, St George-Hyslop P, Mayeux R.
Novel presenilin 1 mutations associated with early onset of dementia in a family
with both early-onset and late-onset Alzheimer disease.
Arch Neurol. 2000 Oct;57(10):1454-7.
PMID: 11030797 [PubMed - indexed for MEDLINE]


5: Hiltunen M, Helisalmi S, Mannermaa A, Alafuzoff I, Koivisto AM, Lehtovirta M,Pirskanen M, Sulkava R, Verkkoniemi A, Soininen H.
Identification of a novel 4.6-kb genomic deletion in presenilin-1 gene which
results in exclusion of exon 9 in a Finnish early onset Alzheimer's disease
family: an Alu core sequence-stimulated recombination?
Eur J Hum Genet. 2000 Apr;8(4):259-66.
PMID: 10854108 [PubMed - indexed for MEDLINE]

1: Molero AE, Pino-Ramirez G, Maestre GE.Modulation by age and gender of risk for Alzheimer's disease and vascular
dementia associated with the apolipoprotein E-varepsilon4 allele in Latin
Americans: findings from the Maracaibo Aging Study.
Neurosci Lett. 2001 Jul 6;307(1):5-8.
PMID: 11516561 [PubMed - indexed for MEDLINE]


2: McPherson S, Back C, Buckwalter JG, Cummings JL.Gender-related cognitive deficits in Alzheimer's disease.
Int Psychogeriatr. 1999 Jun;11(2):117-22.
PMID: 11475426 [PubMed - indexed for MEDLINE]


3: Barrett AM.Probable Alzheimer's disease: gender-related issues.
J Gend Specif Med. 1999 Jan-Feb;2(1):55-60. Review.
PMID: 11252871 [PubMed - indexed for MEDLINE]


4: Sandberg G, Stewart W, Smialek J, Troncoso JC.The prevalence of the neuropathological lesions of Alzheimer's disease is
independent of race and gender.
Neurobiol Aging. 2001 Mar-Apr;22(2):169-75.
PMID: 11182466 [PubMed - indexed for MEDLINE]


5: Hooker K, Manoogian-O'Dell M, Monahan DJ, Frazier LD, Shifren K.Does type of disease matter? Gender differences among Alzheimer's and
Parkinson's disease spouse caregivers.
Gerontologist. 2000 Oct;40(5):568-73.
PMID: 11037935 [PubMed - indexed for MEDLINE]


6: Bullido MJ, Guallar-Castillon P, Artiga MJ, Ramos MC, Sastre I, Aldudo J,Frank A, Coria F, Rodriguez-Artalejo F, Valdivieso F.
Alzheimer's risk associated with human apolipoprotein E, alpha-2 macroglobulin
and lipoprotein receptor related protein polymorphisms: absence of genetic
interactions, and modulation by gender.
Neurosci Lett. 2000 Aug 11;289(3):213-6.
PMID: 10961667 [PubMed - indexed for MEDLINE]


7: Copeland JR, McCracken CF, Dewey ME, Wilson KC, Doran M, Gilmore C, Scott A,Larkin BA.
Undifferentiated dementia, Alzheimer's disease and vascular dementia: age- and
gender-related incidence in Liverpool. The MRC-ALPHA Study.
Br J Psychiatry. 1999 Nov;175:433-8.
PMID: 10789274 [PubMed - indexed for MEDLINE]


8: Sawada H, Udaka F, Izumi Y, Nishinaka K, Kawakami H, Nakamura S, Kameyama M.Cerebral white matter lesions are not associated with apoE genotype but with age
and female sex in Alzheimer's disease.
J Neurol Neurosurg Psychiatry. 2000 May;68(5):653-6.
PMID: 10766901 [PubMed - indexed for MEDLINE]

9: Crawford F, Abdullah L, Schinka J, Suo Z, Gold M, Duara R, Mullan M.Gender-specific association of the angiotensin converting enzyme gene with
Alzheimer's disease.
Neurosci Lett. 2000 Feb 25;280(3):215-9.
PMID: 10675799 [PubMed - indexed for MEDLINE]


10: Ott BR, Lapane KL, Gambassi G.Gender differences in the treatment of behavior problems in Alzheimer's disease.
SAGE Study Group. Systemic Assessment of Geriatric drug use via Epidemiology.
Neurology. 2000 Jan 25;54(2):427-32.
PMID: 10668707 [PubMed - indexed for MEDLINE]


11: Licastro F, Masliah E, Pedrini S, Thal LJ.Blood levels of alpha-1-antichymotrypsin and risk factors for Alzheimer's
disease: effects of gender and apolipoprotein E genotype.
Dement Geriatr Cogn Disord. 2000 Jan-Feb;11(1):25-8.
PMID: 10629358 [PubMed - indexed for MEDLINE]


12: Bretsky PM, Buckwalter JG, Seeman TE, Miller CA, Poirier J, Schellenberg GD,Finch CE, Henderson VW.
Evidence for an interaction between apolipoprotein E genotype, gender, and
Alzheimer disease.
Alzheimer Dis Assoc Disord. 1999 Oct-Dec;13(4):216-21.
PMID: 10609670 [PubMed - indexed for MEDLINE]


13: King DL, Arendash GW, Crawford F, Sterk T, Menendez J, Mullan MJ.Progressive and gender-dependent cognitive impairment in the APP(SW) transgenic
mouse model for Alzheimer's disease.
Behav Brain Res. 1999 Sep;103(2):145-62.
PMID: 10513583 [PubMed - indexed for MEDLINE]


14: Bayles KA, Azuma T, Cruz RF, Tomoeda CK, Wood JA, Montgomery EB Jr.Gender differences in language of Alzheimer disease patients revisited.
Alzheimer Dis Assoc Disord. 1999 Jul-Sep;13(3):138-46.
PMID: 10485572 [PubMed - indexed for MEDLINE]


  1. 15: Craft S, Asthana S, Schellenberg G, Cherrier M, Baker LD, Newcomer J,Plymate S, Latendresse S, Petrova A, Raskind M, Peskind E, Lofgreen C, Grimwood



  2. K.
    Insulin metabolism in Alzheimer's disease differs according to apolipoprotein E
    genotype and gender.
    Neuroendocrinology. 1999 Aug;70(2):146-52.
    PMID: 10461029 [PubMed - indexed for MEDLINE]




16: Gambassi G, Lapane KL, Landi F, Sgadari A, Mor V, Bernabie R.Gender differences in the relation between comorbidity and mortality of patients
with Alzheimer's disease. Systematic Assessment of Geriatric drug use via
Epidemiology (SAGE) Study Group.
Neurology. 1999 Aug 11;53(3):508-16.
PMID: 10449112 [PubMed - indexed for MEDLINE]



  1. 17: Reynolds WF, Rhees J, Maciejewski D, Paladino T, Sieburg H, Maki RA, Masliah

  2. E.
    Myeloperoxidase polymorphism is associated with gender specific risk for
    Alzheimer's disease.
    Exp Neurol. 1999 Jan;155(1):31-41.
    PMID: 9918702 [PubMed - indexed for MEDLINE]




18: MacGowan SH, Wilcock GK, Scott M.Effect of gender and apolipoprotein E genotype on response to anticholinesterase
therapy in Alzheimer's disease.
Int J Geriatr Psychiatry. 1998 Sep;13(9):625-30.
PMID: 9777427 [PubMed - indexed for MEDLINE]


19: Laiacona M, Barbarotto R, Capitani E.Semantic category dissociations in naming: is there a gender effect in
Alzheimer's disease?
Neuropsychologia. 1998 May;36(5):407-19.
PMID: 9699949 [PubMed - indexed for MEDLINE]


20: Combarros O, Leno C, Oterino A, Berciano J, Fernandez-Luna JL,Fernandez-Viadero C, Pena N, Miro J, Delgado M.
Gender effect on apolipoprotein E epsilon4 allele-associated risk for sporadic
Alzheimer's disease.
Acta Neurol Scand. 1998 Jan;97(1):68-71.
PMID: 9482681 [PubMed - indexed for MEDLINE]

1: Morris MC, Scherr PA, Hebert LE, Glynn RJ, Bennett DA, Evans DA.Association of incident Alzheimer disease and blood pressure measured from 13
years before to 2 years after diagnosis in a large community study.
Arch Neurol. 2001 Oct;58(10):1640-6.
PMID: 11594923 [PubMed - indexed for MEDLINE]


2: Morris MC, Scherr PA, Hebert LE, Bennett DA, Wilson RS, Glynn RJ, Evans DA.The cross-sectional association between blood pressure and Alzheimer's disease
in a biracial community population of older persons.
J Gerontol A Biol Sci Med Sci. 2000 Mar;55(3):M130-6.
PMID: 10795724 [PubMed - indexed for MEDLINE]


3: Pasquier F, Leys D.[Blood pressure and Alzheimer's disease]
Rev Neurol (Paris). 1998 Nov;154(11):743-51. Review. French.
PMID: 9894287 [PubMed - indexed for MEDLINE]


4: Siennicki-Lantz A, Lilja B, Rosen I, Elmstahl S.Cerebral blood flow in white matter is correlated with systolic blood pressure
and EEG in senile dementia of the Alzheimer type.
Dement Geriatr Cogn Disord. 1998 Jan-Feb;9(1):29-38.
PMID: 9469263 [PubMed - indexed for MEDLINE]

1: Vlkolinsky R, Cairns N, Fountoulakis M, Lubec G.Decreased brain levels of 2',3'-cyclic nucleotide-3'-phosphodiesterase in Down
syndrome and Alzheimer's disease.
Neurobiol Aging. 2001 Jul-Aug;22(4):547-53.
PMID: 11445254 [PubMed - indexed for MEDLINE]


2: Motonaga K, Itoh M, Hirayama A, Hirano S, Becker LE, Goto Y, Takashima S.Up-regulation of E2F-1 in Down's syndrome brain exhibiting neuropathological
features of Alzheimer-type dementia.
Brain Res. 2001 Jun 29;905(1-2):250-3.
PMID: 11423103 [PubMed - indexed for MEDLINE]


3: Kim SH, Vlkolinsky R, Cairns N, Fountoulakis M, Lubec G.The reduction of NADH ubiquinone oxidoreductase 24- and 75-kDa subunits in
brains of patients with Down syndrome and Alzheimer's disease.
Life Sci. 2001 May 4;68(24):2741-50.
PMID: 11400916 [PubMed - indexed for MEDLINE]


4: Cheon MS, Bajo M, Gulesserian T, Cairns N, Lubec G.Evidence for the relation of herpes simplex virus type 1 to Down syndrome and
Alzheimer's disease.
Electrophoresis. 2001 Feb;22(3):445-8.
PMID: 11258753 [PubMed - indexed for MEDLINE]


5: Yoo BC, Cairns N, Fountoulakis M, Lubec G.Synaptosomal proteins, beta-soluble N-ethylmaleimide-sensitive factor attachment
protein (beta-SNAP), gamma-SNAP and synaptotagmin I in brain of patients with
Down syndrome and Alzheimer's disease.
Dement Geriatr Cogn Disord. 2001 May-Jun;12(3):219-25.
PMID: 11244216 [PubMed - indexed for MEDLINE]


6: Seidl R, Cairns N, Singewald N, Kaehler ST, Lubec G.Differences between GABA levels in Alzheimer's disease and Down syndrome with
Alzheimer-like neuropathology.
Naunyn Schmiedebergs Arch Pharmacol. 2001 Feb;363(2):139-45.
PMID: 11218066 [PubMed - indexed for MEDLINE]


7: Yoo BC, Fountoulakis M, Cairns N, Lubec G.Changes of voltage-dependent anion-selective channel proteins VDAC1 and VDAC2
brain levels in patients with Alzheimer's disease and Down syndrome.
Electrophoresis. 2001 Jan;22(1):172-9.
PMID: 11197169 [PubMed - indexed for MEDLINE]


8: Kim SH, Cairns N, Fountoulakisc M, Lubec G.Decreased brain histamine-releasing factor protein in patients with Down
syndrome and Alzheimer's disease.
Neurosci Lett. 2001 Mar 2;300(1):41-4.
PMID: 11172935 [PubMed - indexed for MEDLINE]

9: Temple V, Jozsvai E, Konstantareas MM, Hewitt TA.Alzheimer dementia in Down's syndrome: the relevance of cognitive ability.
J Intellect Disabil Res. 2001 Feb;45(Pt 1):47-55.
PMID: 11168776 [PubMed - indexed for MEDLINE]


10: Russo C, Salis S, Dolcini V, Venezia V, Song XH, Teller JK, Schettini G.Amino-terminal modification and tyrosine phosphorylation of [corrected]
carboxy-terminal fragments of the amyloid precursor protein in Alzheimer's
disease and Down's syndrome brain.
Neurobiol Dis. 2001 Feb;8(1):173-80.
PMID: 11162251 [PubMed - indexed for MEDLINE]


11: Kim SH, Vlkolinsky R, Cairns N, Lubec G.Decreased levels of complex III core protein 1 and complex V beta chain in
brains from patients with Alzheimer's disease and Down syndrome.
Cell Mol Life Sci. 2000 Nov;57(12):1810-6.
PMID: 11130185 [PubMed - indexed for MEDLINE]


12: Kim SH, Yoo BC, Broers JL, Cairns N, Lubec G.Neuroendocrine-specific protein C, a marker of neuronal differentiation, is
reduced in brain of patients with Down syndrome and Alzheimer's disease.
Biochem Biophys Res Commun. 2000 Sep 16;276(1):329-34.
PMID: 11006125 [PubMed - indexed for MEDLINE]


13: Anderson AJ, Stoltzner S, Lai F, Su J, Nixon RA.Morphological and biochemical assessment of DNA damage and apoptosis in Down
syndrome and Alzheimer disease, and effect of postmortem tissue archival on
TUNEL.
Neurobiol Aging. 2000 Jul-Aug;21(4):511-24.
PMID: 10924764 [PubMed - indexed for MEDLINE]


14: Deb S, Braganza J, Norton N, Williams H, Kehoe PG, Williams J, Owen MJ.APOE epsilon 4 influences the manifestation of Alzheimer's disease in adults
with Down's syndrome.
Br J Psychiatry. 2000 May;176:468-72.
PMID: 10912224 [PubMed - indexed for MEDLINE]


15: Cataldo AM, Peterhoff CM, Troncoso JC, Gomez-Isla T, Hyman BT, Nixon RA.Endocytic pathway abnormalities precede amyloid beta deposition in sporadic
Alzheimer's disease and Down syndrome: differential effects of APOE genotype and
presenilin mutations.
Am J Pathol. 2000 Jul;157(1):277-86.
PMID: 10880397 [PubMed - indexed for MEDLINE]


16: Stoltzner SE, Grenfell TJ, Mori C, Wisniewski KE, Wisniewski TM, Selkoe DJ,Lemere CA.
Temporal accrual of complement proteins in amyloid plaques in Down's syndrome
with Alzheimer's disease.
Am J Pathol. 2000 Feb;156(2):489-99.
PMID: 10666378 [PubMed - indexed for MEDLINE]

1: Kapaki E, Kilidireas K, Paraskevas GP, Michalopoulou M, Patsouris E.Highly increased CSF tau protein and decreased beta-amyloid (1-42) in sporadic
CJD: a discrimination from Alzheimer's disease?
J Neurol Neurosurg Psychiatry. 2001 Sep;71(3):401-3.
PMID: 11511720 [PubMed - indexed for MEDLINE]


2: Mao JJ, Katayama S, Watanabe C, Harada Y, Noda K, Yamamura Y, Nakamura S.The relationship between alphaB-crystallin and neurofibrillary tangles in
Alzheimer's disease.
Neuropathol Appl Neurobiol. 2001 Jun;27(3):180-8.
PMID: 11489137 [PubMed - indexed for MEDLINE]


3: Garcia-Sierra F, Wischik CM, Harrington CR, Luna-Munoz J, Mena R.Accumulation of C-terminally truncated tau protein associated with vulnerability
of the perforant pathway in early stages of neurofibrillary pathology in
Alzheimer's disease.
J Chem Neuroanat. 2001 Jul;22(1-2):65-77.
PMID: 11470555 [PubMed - indexed for MEDLINE]


4: Shen Y, Lue L, Yang L, Roher A, Kuo Y, Strohmeyer R, Goux WJ, Lee V, JohnsonGV, Webster SD, Cooper NR, Bradt B, Rogers J.
Complement activation by neurofibrillary tangles in Alzheimer's disease.
Neurosci Lett. 2001 Jun 15;305(3):165-8.
PMID: 11403931 [PubMed - indexed for MEDLINE]


5: Delatour B, Mercken L, El Hachimi KH, Colle MA, Pradier L, Duyckaerts C.FE65 in Alzheimer's disease: neuronal distribution and association with
neurofibrillary tangles.
Am J Pathol. 2001 May;158(5):1585-91.
PMID: 11337355 [PubMed - indexed for MEDLINE]


6: Imamura K, Sawada M, Ozaki N, Naito H, Iwata N, Ishihara R, Takeuchi T,Shibayama H.
Activation mechanism of brain microglia in patients with diffuse neurofibrillary
tangles with calcification: a comparison with Alzheimer disease.
Alzheimer Dis Assoc Disord. 2001 Jan-Mar;15(1):45-50.
PMID: 11236824 [PubMed - indexed for MEDLINE]


7: Chen M, Fernandez HL.Where do Alzheimer's plaques and tangles come from? Aging-induced protein
degradation inefficiency.
Front Biosci. 2001 Mar 1;6:E1-E11. Review.
PMID: 11229869 [PubMed - indexed for MEDLINE]


8: Paradowski B, Szczepaniak M, Dobosz T, Sasiadek M.[Apolipoprotein E(ApoE)and tau protein in Alzheimer type dementia]
Pol Merkuriusz Lek. 2000 Nov;9(53):758-9. Polish.
PMID: 11204323 [PubMed - indexed for MEDLINE]

9: Chin JY, Knowles RB, Schneider A, Drewes G, Mandelkow EM, Hyman BT.Microtubule-affinity regulating kinase (MARK) is tightly associated with
neurofibrillary tangles in Alzheimer brain: a fluorescence resonance energy
transfer study.
J Neuropathol Exp Neurol. 2000 Nov;59(11):966-71.
PMID: 11089574 [PubMed - indexed for MEDLINE]


10: Mori H.Untangling Alzheimer's disease from fibrous lesions of neurofibrillary tangles
and senile plaques.
Neuropathology. 2000 Sep;20 Suppl:S55-60. Review.
PMID: 11037189 [PubMed - indexed for MEDLINE]


11: Colle MA, Duyckaerts C, Laquerriere A, Pradier L, Czech C, Checler F, HauwJJ.
Laminar specific loss of isocortical presenilin 1 immunoreactivity in
Alzheimer's disease. Correlations with the amyloid load and the density of
tau-positive neurofibrillary tangles.
Neuropathol Appl Neurobiol. 2000 Apr;26(2):117-23.
PMID: 10840274 [PubMed - indexed for MEDLINE]


12: Sheffield LG, Marquis JG, Berman NE.Regional distribution of cortical microglia parallels that of neurofibrillary
tangles in Alzheimer's disease.
Neurosci Lett. 2000 May 19;285(3):165-8.
PMID: 10806312 [PubMed - indexed for MEDLINE]


13: von Bergen M, Friedhoff P, Biernat J, Heberle J, Mandelkow EM, Mandelkow E.Assembly of tau protein into Alzheimer paired helical filaments depends on a
local sequence motif ((306)VQIVYK(311)) forming beta structure.
Proc Natl Acad Sci U S A. 2000 May 9;97(10):5129-34.
PMID: 10805776 [PubMed - indexed for MEDLINE]


14: Uboga NV, Price JL.Formation of diffuse and fibrillar tangles in aging and early Alzheimer's
disease.
Neurobiol Aging. 2000 Jan-Feb;21(1):1-10.
PMID: 10794842 [PubMed - indexed for MEDLINE]


15: Takahashi M, Iseki E, Kosaka K.Cdk5 and munc-18/p67 co-localization in early stage neurofibrillary
tangles-bearing neurons in Alzheimer type dementia brains.
J Neurol Sci. 2000 Jan 1;172(1):63-9.
PMID: 10620662 [PubMed - indexed for MEDLINE]


16: Sayre LM, Perry G, Harris PL, Liu Y, Schubert KA, Smith MA.In situ oxidative catalysis by neurofibrillary tangles and senile plaques in
Alzheimer's disease: a central role for bound transition metals.
J Neurochem. 2000 Jan;74(1):270-9.
PMID: 10617129 [PubMed - indexed for MEDLINE]

1   2   3   4   5   6   7   8   9

similar:

¿Qué es la enfermedad de Alzheimer? icon¿QUÉ tal que ya existiera la cura para la enfermedad de alzheimer y nadie lo supiera?

¿Qué es la enfermedad de Alzheimer? iconEnfermedad de Alzheimer

¿Qué es la enfermedad de Alzheimer? iconEnfermedad de Alzheimer De Wikipedia, la enciclopedia libre

¿Qué es la enfermedad de Alzheimer? iconConclusiones "Los costes de la enfermedad de Alzheimer"

¿Qué es la enfermedad de Alzheimer? iconSujeciones químicas en personas con enfermedad de Alzheimer

¿Qué es la enfermedad de Alzheimer? iconEfectos del ejercicio multimodal en pacientes con la enfermedad de...

¿Qué es la enfermedad de Alzheimer? icon¿Qué es una enfermedad transmitida por alimentos?

¿Qué es la enfermedad de Alzheimer? icon1. Explica en qué consiste la progeria e indica los problemas de...

¿Qué es la enfermedad de Alzheimer? iconAula 1 Química. Campus Libertad. Av Libertad 5470. Corrientes
«sin carga», entendiéndose por carga un impuesto, ley o enfermedad. Se dice que aquellos individuos que no sucumben ante la enfermedad...

¿Qué es la enfermedad de Alzheimer? icon¿Qué provoca el enfrentamiento de Sempronio y Celestina?(pp. 120-121)...
«pecado» para Celestina? ¿Qué remedio infalible le sugiere a Areúsa para curar su mal? (p. 154) ¿Qué última lección le da Celestina...


Medicina





Todos los derechos reservados. Copyright © 2015
contactos
med.se-todo.com